Dutch insurer ASR Nederland reported a record first-half 2026 operating profit, driven by strong underwriting performance and pension buyout inflows. Operating capital contribution rose 7.1% year-over-year to €773 million, while operating profit increased 9.8% to €901 million. The company's Solvency II ratio improved to 222%, up from 218% at year-end 2025.
The insurer raised its interim dividend by 9.1% to €1.39 per share, yielding 4.82%. Operating return on equity exceeded 15%, surpassing the 12% target. ASR completed a €175 million share buyback program in the period.
Non-life underwriting performance strengthened, with the combined ratio for property and casualty and disability insurance improving to 91.6%, better than the target range of 92% to 94%. Property and casualty alone recorded a combined ratio of 89.9%, while health insurance remained at 99.6%, serving a customer base of over 700,000.
Pension-related business expanded, with defined contribution pension inflows reaching €1.5 billion. Assets under management in this segment grew 14% to €34 billion, while annuity inflows rose 38%. Pension buyout transactions added over €200 million to assets under management in the first half, with an additional €150 million Ecolab transaction announced for the second half. ASR's medium-term ambition in pension buyouts remains €8 billion.
Fee income surged 33% to €150 million, while mortgage production totaled €3.6 billion. The insurer's stock traded at $70.72 at the time of the earnings release, down 0.06% from the previous close, with a year-to-date return of 20.6% and a 52-week range of $55.88 to $71.54.
CEO Ingrid de Swart highlighted profitable growth and platform strengthening, noting the completion of the Aegon Nederland integration and the July closure of the Bovemij acquisition. CFO Ewout Hollegien emphasized the company's strong capital position, providing flexibility for growth and capital returns.
ASR expects second-half operating capital contribution to remain below €600 million, with the full-year 2026 target set at €1.35 billion. The insurer is scheduled to present updated strategy and targets at a Capital Markets Day on December 1, 2026.
